Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries

Fig. 2

Proportion of swollen joints at individual locations of the 28-joint count at follow-up visits after start of treatment with the first tumour necrosis factor inhibitor (TNFi) in joints that were swollen at baseline (BL). The proportions were calculated in relation to the total number of joints assessed at 6, 12, 18, and 24 months. A Joints located along a proximal–distal axis of the upper extremity and the knee. B Joints positioned along an anterior–posterior axis of the hand (digits 1–5). Metacarpophalangeal and proximal interphalangeal joints of each digit were combined for analysis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us